½ÃÀ庸°í¼­
»óǰÄÚµå
1601104

±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Near Infrared Imaging Market by Product (Devices, Dyes, Reagents), Application (Cancer Surgeries, Cardiovascular Surgeries, Gastrointestinal Surgeries), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀåÀº 2023³â¿¡ 25¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2024³â¿¡´Â 26¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.22%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 36¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±ÙÀû¿Ü¼± ¿µ»ó(NIR)À̶õ, ±Ù Àû¿Ü¼±À» ÀÌ¿ëÇØ Á¶Á÷ »ý¸®ÇÐÀû Á¤º¸¸¦ ¾ò´Â ±â¼ú ÀÏ·Î, ÀÇ·á Áø´Ü, ³ó¾÷, »ê¾÷ ºÐ¾ß¿¡¼­ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ±× ºñħ½ÀÀûÀÎ ¼ºÁú¿¡ ÀÇÇØ ±âÁ¸ À̹Ì¡ ±â¼ú·Î´Â ºÒÃæºÐÇßÁö¸¸ °¨Áö, ³ú¿µ»ó, ¼ö¼ú ÁßÇ÷·ù¸ð´ÏÅ͸µµîÀÇ ¿ëµµ¿¡ ÇʼöÀûÀÔ´Ï´Ù. NIR À̹Ì¡ ÀÀ¿ë¹üÀ§´Â ÀÇ·á Áø´Ü¿¡ ¸Ó¹«¸£Áö ¾Ê°í, ½Äǰ ǰÁú Æò°¡, ÀǾàǰ ºÐ¼®, ¹ýÀÇÇÐÀû °Ë»ç µî, ÃÖÁ¾ ¿ëµµ¸¦ ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡ ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 25¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 26¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 36¾ï ´Þ·¯
CAGR(%) 5.22%

NIR À̹Ì¡ ½ÃÀå ÁÖ¿ä ¼ºÀå¿äÀÎÀº ¼¾¼­ ±â¼ú Çõ½ÅÀÌ ÁøÇàµÇ°í ÀÖ´Â °ÍÀ¸·Î, ÷´Ü Áø´Ü Çʿ伺À» °­Á¶ÇÏ´Â ÇコÄɾî ÅõÀÚ Áõ°¡ÀÔ´Ï´Ù. Àα¸ °í·ÉÈ­¿Í ¸¸¼ºÁúȯ Áõ°¡¿¡ ÀÇÇØ À̹Ì¡ ±â¼ú Çâ»óÀÌ ÇÑÃþ ´õ ÇÊ¿äÇÏ°Ô µÇ°í ÀÖ¾î Å« ½ÃÀå °¡´É¼ºÀ» Àº¹ÐÇÑÀ̶ó°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á ºÎ»ó¿¡ ÀÇÇØ NIR À̹Ì¡Àº Ä¡·á ¼º°ú¸¦ ³ôÀÌ´Â ÁÖ¿ä ÀλçÀÌÆ®À» Á¦°øÇØ, »õ·Î¿î ±âȸ¸¦ ³º°í ÀÖ½À´Ï´Ù. ±×·¯³ª, Ãʱ⠺ñ¿ë ³ôÀÌ, ±â¼úÀûÀÎ º¹À⼺, ¼÷·ÃÀÚ Çʿ伺À̶ó°í ÇÏ´Â °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ¾î, º¸±Þ ¹æÇذ¡ µÇ°í ÀÖ½À´Ï´Ù.

ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ¶ó°í ÇÏ´Â Á¡¿¡¼­´Â ±â¾÷Àº ±âÁ¸ ½Ã½ºÅÛ¿¡ °£´ÜÇÏ°Ô Â¥³ÖÀ» ¼ö ÀÖ´Â ºñ¿ë È¿À² ³ôÀº ÈÞ´ë¿ë NIR Àåºñ °³¹ß¿¡ ÁÖ·Â ÇØ¾ß ÇÕ´Ï´Ù. ³ó¾÷À̳ª ȯ°æ ¸ð´ÏÅ͸µ °°Àº ºñÀüÅëÀû ºÐ¾ß¿¡ÀÇ ÀÀ¿ëÀ» È®´ëÇϸé, »õ·Î¿î ¼öÀÔ¿øÀ» Á¦°øÇÒ ¼ö ÀÖ´Ù°í »ý°¢µË´Ï´Ù. Çмú±â°ü°úÀÇ °øµ¿ ¿¬±¸¿¡ ÀÓÇØ, ¿µ»ó ó¸®À» À§ÇÑ AI³ª ¸Ó½Å·¯´×¿¡ ÅõÀÚÇÏ´Â Àϵµ ¼ºÀåÀ» °¡¼ÓÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª, ±ÔÁ¦»ó ÇãµéÀ̳ª ÀÓ»óÀû °ËÁõ Çʿ伺¿¡´Â ÇѰ谡 ÀÖ¾î, À̰ÍÀ» ±Øº¹ÇÏ·Á¸é Àü·«Àû °èȹÀÌ ÇÊ¿äÇÕ´Ï´Ù.

Çõ½Å ¸ñÇ¥´Â ¿µ»ó ÇØ»óµµ¿Í Á¤µµ¸¦ Çâ»ó½ÃÄÑ, µ¿½Ã¿¡ ºñ¿ëÀ» »è°¨ÇÏ´Â °ÍÀÔ´Ï´Ù. ȯ°æ¿¡ ÁÁ°í ¿¡³ÊÁö È¿À² ³ôÀº ¼³°è¸¦ ¿ì¼±ÇÏ´Â °ÍÀ¸·Î, Áö¼Ó°¡´É¼ºÀ» Áß½ÃÇÏ´Â Ãþ¿¡ ¾îÇÊÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀÌ ÁøÈ­ÇÏ´Â Áß, À¯¿¬ÇÑ ¿¬±¸°³¹ß Á¢±ÙÀ» À¯ÁöÇÏ´Â °ÍÀº »õ·Î¿î µ¿Çâ¿¡ ÀûÀÀÇØ, ±ÙÀû¿Ü¼± ¿µ»ó ´ÙÀ̳ª¹ÍÇÑ »óȲ¿¡¼­ °æÀï·ÂÀ» À¯ÁöÇϱâ À§Çؼ­ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³

±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀåÀº ¼ö¿ä ¹× °ø±Þ ´ÙÀ̳ª¹ÍÇÑ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ¼­ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐ ÁøÈ­¸¦ ÀÌÇØÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû °áÁ¤ Á¤Ä¡È­, ±×¸®°í »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº Á¤Ä¡Àû, Áö¿ª ¸ñÇ¥, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °Ç³Ê°¡´Â ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖ¾î ¶ÇÇÑ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¿Ü°ú ¼ö¼úÀ̳ª ¼ö¼ú Áß Ä¡·á ¿ëµµ È®´ë
    • ¼¼°èÀÇ ºñħ½ÀÀû Áø´Ü¹ý¿¡ÀÇ ¼±È£µµ Áõ°¡
    • °Ç°­ ¸ð´ÏÅ͸µÀ» À§ÇÑ °¡ÀüÁ¦Ç°¿¡ÀÇ Â¥³Ö¾î
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • NIR À̹Ì¡¡¤½Ã½ºÅÛ ±â¼úÀû ÇѰè
  • ½ÃÀå ±âȸ
    • ±ÙÀû¿Ü¼± ¿µ»ó ¼³°è¿Í ¼º´É Áøº¸
    • ÀǾàǰ ǰÁú°ü¸® NIR À̹Ì¡ ÀÌ¿ë È®´ë
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • NIR À̹Ì¡¿¡ ¼ö¹ÝÇÏ´Â °Ç°­ ÇÇÇØ

Æ÷ÅÍ 5»ì ·Â : ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀåÀ» ¾È³»ÇÏ´Â Àü·« Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå ±¸µµ °æÀï ±¸µµ¸¦ ÀÌÇØÇϱâ À§ÇÑ Áß¿ä ÅøÀÔ´Ï´Ù. Porter's Five Forces¡¤ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ °æÀï·ÂÀ» Æò°¡ÇØ, Àü·«Àû ±âȸ¸¦ ã±â À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇØ, ½Å±Ô »ç¾÷ ¼öÀͼºÀ» ÆÇ´ÜÇϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû¿¡ ÀÇÇØ ±â¾÷Àº ÀÚ»ç °­Á¡À» »ì·Á, ¾àÁ¡¿¡ ´ëÃ³ÇØ, ÀáÀçÀûÀÎ °úÁ¦¸¦ ȸÇÇÇÒ ¼ö À־´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå ¿ÜºÎ·ÎºÎÅÍ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ãȯ°æ ¿äÀÎÀº ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå ½ÇÀû ¿ªÇÐÀ» Çü¼ºÇϴµ¥ À־ ¸Å¿ì Áß¿ä ¿ªÇÒÀ» ¿Ï¼öÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» ¾È³»Çϱâ À§Çؼ­ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÀáÀçÀûÀÎ ¸®½ºÅ©¿Í ±âȸ¸¦ º¸´Ù ÁÁ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¿¡ ÀÇÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿Çâ º¯È­¸¦ ¿¹ÃøÇØ, ¾ÕÀ» ¿¹ÃøÇÑ Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ½Ç½ÃÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼®±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®¿¡ ÀÇÇØ º¥´õ ½ÇÀûÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·üµîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ´Â °ÍÀ¸·Î, °æÀï»ó Æ÷Áö¼Å´×À» ºÐ¸íÈ÷ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¿¡ ÀÇÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀÌ ¹àÇôÁ®, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ»ç ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ½Ç½ÃÇϱâ À§Çؼ­ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå º¥´õ ÆÛÆ÷¸Õ½º Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡Çϱâ À§ÇÑ Áß¿ä ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¿¡ ÀÇÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¿¡ ±Ù°ÅÇØ Æò°¡ÇÏ´Â °ÍÀ¸·Î, ¸ñÇ¥¿¡ µû¸¥ ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç°áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. 4°³ »óÇÑÀº º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇØ, »ç¿ëÀÚ°¡ Àü·« ¸ñÇ¥·Î ÃÖÀûÀÎ ÆÄÆ®³Ê³ª ¼Ö·ç¼ÇÀ» ƯÁ¤Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.

º» º¸°í¼­´Â ÁÖ¿ä ÁÖ¸ñ ºÐ¾ß¸¦ ¸Á¶óÇÑ Á¾ÇÕÀû½ÃÀå ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù :

1.½ÃÀå ħÅõµµ : ¾÷°è ÁÖ¿ä ±â¾÷ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æ »ó¼¼ÇÑ ¸®ºä.

2.½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå ¼ºÀå ±âȸ¸¦ ƯÁ¤ÇØ, ±âÁ¸ ºÐ¾ß È®´ë °¡´É¼ºÀ» Æò°¡ÇØ, ÇâÈÄ ¼ºÀåÀ» ÇâÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3.½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° ¹ß¸Å, ¹Ì°³Ã´ Áö¿ª, ¾÷°è ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4.°æÀï Æò°¡¿Í Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÇÏ°Ô ºÐ¼®ÇÏ°í ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦±â°ü ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ ±â¼ú Áøº¸µîÀ» °ËÁõ ÇÕ´Ï´Ù.

5.Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÑ´Ù°í ±â´ëµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» ÇÏÀ̶óÀÌÆ® Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ´ÙÀ½ ÀÇ»ç°áÁ¤ ÇÒ ¼ö ÀÖµµ·Ï, Áß¿ä Áú¹®¿¡µµ ´äÇϰí ÀÖ½À´Ï´Ù :

1.ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2.ÃÖ°í ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµò°¡?

3.½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ ¿µÇâÀ̶õ?

4.ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå Âü¿©¡¤Ã¶Åð Àü·« ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå : Á¦Ç°º°

  • µð¹ÙÀ̽º
    • ±ÙÀû¿Ü¼± »ý¹° ¹ß±¤ À̹Ì¡ ½Ã½ºÅÛ
    • ±ÙÀû¿Ü Çü±¤ À̹Ì¡ ½Ã½ºÅÛ
    • NIR ±¤°£¼· ´ÜÃþÃÔ¿µ
    • NIR ºÐ±¤°è
  • ¿°·á
    • ³ª³ëÀÔÀÚ ¿°·á
    • À¯±â ¿°·á
  • ½Ã¾à
    • Indocyanine Green
    • Methylene Blue

Á¦7Àå ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå : ¿ëµµº°

  • ¾Ï¼ö¼ú
  • ½ÉÀåÇ÷°ü ¼ö¼ú
  • ¼ÒÈ­±â¿Ü°ú ¼ö¼ú
  • ¼ºÇü¿Ü°ú/Àç°Ç ¼ö¼ú
  • ÀüÀÓ»ó À̹Ì¡

Á¦8Àå ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø ¹× Ŭ¸®´Ð
  • Á¦¾à ±â¾÷ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ¿¬±¸½Ç

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±ÙÀû¿Ü¼± ¿µ»ó ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®

±â¾÷ ¸®½ºÆ®

  • Abbott Laboratories
  • Artinis Medical Systems
  • Astellas Pharma Inc.
  • BIOPAC Systems, Inc.
  • Biotium, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Crysta-Lyn Chemical Company
  • DIC Corporation
  • Emberion Oy
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • KARL STORZ SE & Co. KG
  • Leica Microsystems GmbH by Danaher Corporation
  • LI-COR Biotech LLC
  • Malvern Panalytical Ltd. by Spectris PLC
  • Medtronic PLC
  • Metrohm AG
  • MIZUHO Corporation
  • Nikon Corporation
  • Olympus Corporation
  • OptoMedic Technologies, Inc.
  • PerkinElmer Inc.
  • SCHOLLY FIBEROPTIC GMBH
  • Shimadzu Corporation
  • Soterix Medical Inc.
  • SpectraWAVE, Inc.
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
LSH 24.12.06

The Near Infrared Imaging Market was valued at USD 2.52 billion in 2023, expected to reach USD 2.65 billion in 2024, and is projected to grow at a CAGR of 5.22%, to USD 3.60 billion by 2030.

Near-infrared imaging (NIR) refers to a technique that utilizes near-infrared light to obtain physiological information of tissues, commonly used in medical diagnostics, agricultural, and industrial sectors. Its non-invasive nature makes it vital for applications like cancer detection, brain imaging, and intraoperative blood flow monitoring, where traditional imaging techniques may fall short. The scope of NIR imaging extends beyond medical diagnostics to include applications in food quality assessment, pharmaceutical analysis, and forensic inspections, thereby broadening its end-use context to diverse industrial sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 2.52 billion
Estimated Year [2024] USD 2.65 billion
Forecast Year [2030] USD 3.60 billion
CAGR (%) 5.22%

A key growth driver for the NIR imaging market is the ongoing innovation in sensor technology and increasing healthcare investments that underscore its necessity in advanced diagnostics. The aging population and rising prevalence of chronic diseases further necessitate improved imaging techniques, offering significant market potential. Furthermore, with the rise of personalized medicine, NIR imaging provides crucial insights that could enhance treatment outcomes, thereby creating new opportunities. However, the market faces challenges such as high initial costs, technical complexities, and a need for skilled personnel, which can hinder widespread adoption.

In terms of potential opportunities, businesses should focus on developing cost-effective, portable NIR devices that can be easily integrated into existing systems. Expanding applications in non-traditional sectors like agriculture or environmental monitoring could provide new revenue streams. Engaging in collaborative research with academic institutions and investing in AI and machine learning for image processing could also drive growth. However, regulatory hurdles and the need for clinical validation present limitations that need strategic planning to overcome.

Innovation should target enhancing image resolution and accuracy while reducing costs to encourage wider adoption. Prioritizing eco-friendly and energy-efficient designs could appeal to sustainability-minded segments. As the market evolves, maintaining a flexible R&D approach will be crucial for adapting to emerging trends and staying competitive in the dynamic landscape of near-infrared imaging.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Near Infrared Imaging Market

The Near Infrared Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing application in surgical procedures and intraoperative treatments
    • Surging preference for non-invasive diagnostic methods worldwide
    • Incorporation into consumer electronics for health monitoring
  • Market Restraints
    • Technical limitations of NIR imaging systems
  • Market Opportunities
    • Advancements in the design and performance of near infrared imaging
    • Emerging use of NIR imaging for pharmaceutical quality control
  • Market Challenges
    • Health hazards associated with NIR imaging

Porter's Five Forces: A Strategic Tool for Navigating the Near Infrared Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Near Infrared Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Near Infrared Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Near Infrared Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Near Infrared Imaging Market

A detailed market share analysis in the Near Infrared Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Near Infrared Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Near Infrared Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Near Infrared Imaging Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Artinis Medical Systems, Astellas Pharma Inc., BIOPAC Systems, Inc., Biotium, Inc., Bruker Corporation, Carl Zeiss AG, Crysta-Lyn Chemical Company, DIC Corporation, Emberion Oy, Getinge AB, Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Leica Microsystems GmbH by Danaher Corporation, LI-COR Biotech LLC, Malvern Panalytical Ltd. by Spectris PLC, Medtronic PLC, Metrohm AG, MIZUHO Corporation, Nikon Corporation, Olympus Corporation, OptoMedic Technologies, Inc., PerkinElmer Inc., SCHOLLY FIBEROPTIC GMBH, Shimadzu Corporation, Soterix Medical Inc., SpectraWAVE, Inc., Stryker Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Near Infrared Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Devices, Dyes, and Reagents. The Devices is further studied across Near-Infrared Bioluminescence Imaging Systems, Near-Infrared Fluorescence Imaging Systems, NIR Optical Coherence Tomography, and NIR Spectrometers. The Dyes is further studied across Nanoparticle Dyes and Organic Dyes. The Reagents is further studied across Indocyanine Green and Methylene Blue.
  • Based on Application, market is studied across Cancer Surgeries, Cardiovascular Surgeries, Gastrointestinal Surgeries, Plastic/Reconstructive Surgeries, and Preclinical Imaging.
  • Based on End User, market is studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing application in surgical procedures and intraoperative treatments
      • 5.1.1.2. Surging preference for non-invasive diagnostic methods worldwide
      • 5.1.1.3. Incorporation into consumer electronics for health monitoring
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations of NIR imaging systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the design and performance of near infrared imaging
      • 5.1.3.2. Emerging use of NIR imaging for pharmaceutical quality control
    • 5.1.4. Challenges
      • 5.1.4.1. Health hazards associated with NIR imaging
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Introduction of advanced NIR imaging systems that provide real-time, high-resolution images
    • 5.2.2. Application: Exponential adoption of NIR imaging in cancer surgeries for accurate discrimination of cancerous tissues
    • 5.2.3. End User: Use of NIR technologies in hospitals and diagnostic centers to support clinical decision-making and improve patient care standards
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Near Infrared Imaging Market, by Product

  • 6.1. Introduction
  • 6.2. Devices
    • 6.2.1. Near-Infrared Bioluminescence Imaging Systems
    • 6.2.2. Near-Infrared Fluorescence Imaging Systems
    • 6.2.3. NIR Optical Coherence Tomography
    • 6.2.4. NIR Spectrometers
  • 6.3. Dyes
    • 6.3.1. Nanoparticle Dyes
    • 6.3.2. Organic Dyes
  • 6.4. Reagents
    • 6.4.1. Indocyanine Green
    • 6.4.2. Methylene Blue

7. Near Infrared Imaging Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer Surgeries
  • 7.3. Cardiovascular Surgeries
  • 7.4. Gastrointestinal Surgeries
  • 7.5. Plastic/Reconstructive Surgeries
  • 7.6. Preclinical Imaging

8. Near Infrared Imaging Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research Laboratories

9. Americas Near Infrared Imaging Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Near Infrared Imaging Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Near Infrared Imaging Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Abbott Launches New Vascular Imaging Platform in India
    • 12.3.2. SpectraWAVE Secures 510(k) Clearance to Add Saline Imaging and Expanded Artificial Intelligence Features to the HyperVue Imaging System
    • 12.3.3. Nikon Introduces the AX R MP with NSPARC Super-resolution Multiphoton Confocal Microscope
    • 12.3.4. Photonis Announces Agreement to Acquire Telops, a min Hyperspectral Infra-Red Imaging Solutions
    • 12.3.5. Olympus Launches VISERA ELITE III Surgical Visualization Platform
    • 12.3.6. Shimadzu Unveils Near-Infrared Light Imaging System to Enhance Drug Discovery Research
    • 12.3.7. Getinge Acquires Expert in Near Infrared Imaging Technology, Fluoptics
    • 12.3.8. Emberion Raises EUR 6 million For its Infrared Imaging Business

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Artinis Medical Systems
  • 3. Astellas Pharma Inc.
  • 4. BIOPAC Systems, Inc.
  • 5. Biotium, Inc.
  • 6. Bruker Corporation
  • 7. Carl Zeiss AG
  • 8. Crysta-Lyn Chemical Company
  • 9. DIC Corporation
  • 10. Emberion Oy
  • 11. Getinge AB
  • 12. Hamamatsu Photonics K.K.
  • 13. KARL STORZ SE & Co. KG
  • 14. Leica Microsystems GmbH by Danaher Corporation
  • 15. LI-COR Biotech LLC
  • 16. Malvern Panalytical Ltd. by Spectris PLC
  • 17. Medtronic PLC
  • 18. Metrohm AG
  • 19. MIZUHO Corporation
  • 20. Nikon Corporation
  • 21. Olympus Corporation
  • 22. OptoMedic Technologies, Inc.
  • 23. PerkinElmer Inc.
  • 24. SCHOLLY FIBEROPTIC GMBH
  • 25. Shimadzu Corporation
  • 26. Soterix Medical Inc.
  • 27. SpectraWAVE, Inc.
  • 28. Stryker Corporation
  • 29. Thermo Fisher Scientific Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦